delavirdine


Also found in: Thesaurus, Medical, Wikipedia.

del·a·vir·dine

 (dĕl′ə-vîr′dēn)
n.
An antiviral drug, C22H28N6O3S, that is a non-nucleoside reverse transcriptase inhibitor and is used in its mesylate form in combination with other drugs for the treatment of HIV infection.

[dela- (perhaps alteration of dimethyl) + -virdine, antiviral pyridine derivative suffix ((anti)vir(al) + (pyri)dine).]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.delavirdine - a non-nucleoside reverse transcriptase inhibitor (trade name Rescriptor) used to treat AIDS and HIV
NNRTI, non-nucleoside reverse transcriptase inhibitor - an antiviral drug used against HIV; binds directly to reverse transcriptase and prevents RNA conversion to DNA; often used in combination with other drugs
Translations

delavirdine

n delavirdina
References in periodicals archive ?
NNRTIs include rilpivirine (Edurant[R]), etravirine (Intelence[R]), delavirdine (Rescriptor[R]), efavirenz (Sustiva[R]), and nevirapine (Viramune[R]) (AIDSinfo, 2016; FDA, 2016).
[19] Nevirapine, delavirdine and efavirenz, abacavir, amprenavir cause rashes frequently due to hypersensitivity which usually resolve spontaneously.
They include delavirdine (Rescriptor), efavirenz (Sustiva, Stocrin), nevirapine (Viramune) and etravirine (Intelence).
In addition, patients received delavirdine with or without adefovir.
De los 25 medicamentos aprobados, tres no se manufacturan debido a que se esta fabricando una presentacion mejorada de los mismos (ej., amprenavir * remplazado por fosamprenavir) o por su uso limitado (ej., delavirdine y zalcitabina).
In this study, one primary NNRTI mutation (Y181C) was observed (Y181C mutation causes high-level resistance to nevirapine and delavirdine and low-level resistance to efavirenz), while no primary NRTI mutation was noted.
Mutations associated with minor resistance to protease inhibitors (L10I) and non-nucleoside reverse transcription inhibitors (E138A) were detected in sequences from patient TV919, and a mutation conferring high-level resistance to delavirdine (P236L) was detected in patient TV725.
Two types of ARV drugs--nonnucleoside reverse transcriptase inhibitors (NNRTIs), including delavirdine, nevirapine and efavirenz, and protease inhibitors (PIs), such as ritonavir, nelfinavir, lopinavir, saquinavir, and indinavir--are all susceptible to increased liver metabolism as a result of alcohol-mediated induction of the CYP3A4 enzyme system.
FDA-Approved Antiretroviral Agents Nucleoside RTIs Nonnucleoside RTIs Protease inhibitors abacavir (ABC) delavirdine (DLV) atazanavir (ATV) didanosine (ddl) efavirenz (EFZ) darunavir (DRV) emtricitabine (FTC) etravirine (ETV) fosamprenavir (Fos-APV) lamivudine (3TC) nevirapine (NVP) indinavir (IDV) stavudine (d4T) lopinavir/r (LPV/r) zidovudine (ZDV) nelfinavir (NFV) ritonavir (RTV) saquinavir (SQV) tipranavir (TPV) Nucleotide RTI Integrase inhibitor Fusion inhibitor tenofovir DF (TDF) raltegravir (RAL) enfuvirtide (T-20) CCR5 antagonist maraviroc (MVC) Notes: Six fixed-dose combinations are approved by the Food and Drug Administration.
Mean duration of each antiretroviral exposure Antiretroviral Mean duration of exposure (months) Zidovudine 26 Stavudine 23 Lamivudine 40 Didanosine 8.5 Zalcitabine 11 Abacavir 6 Tenofovir 9 Efavirenz 10.5 Nevirapine 10 Delavirdine 3 Ritonavir 8 Saquinavir 2 Indinavir 11 Nelfinavir 11 Atazanavir 10 Amprenavir 6 Saquinavir/ritonavir 8.5 Indinavir/ritonavir 8 Atazanavir/ritonavir 7 Amprenavir/ritonavir 9 Lopinavir/ritonavir 3 Darunavir/ritonavir 10.5 Table 4.
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359.
(56) Since then, other scientists have loaded nanoparticles with zidovudine, (57-61) didanosine, (62,63) stavudine, (64) lamivudine, (57) delavirdine, (64) efavirenz, (65-67) indinavir, (68,69) ritonavir (67,70) and lopinavir.